Premium
Light‐Emitting Diode treatment ameliorates allergic lung inflammation in experimental model of asthma induced by ovalbumin
Author(s) -
Siqueira Vanessa Perosino Cardoso,
Evangelista Marina Izadora Silveira,
dos Santos Alana,
Marcos Rodrigo Labat,
LigeirodeOliveira Ana Paula,
Pavani Christiane,
Damazo Amílcar Sabino,
LinodosSantosFranco Adriana
Publication year - 2017
Publication title -
journal of biophotonics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.877
H-Index - 66
eISSN - 1864-0648
pISSN - 1864-063X
DOI - 10.1002/jbio.201600247
Subject(s) - ovalbumin , medicine , inflammation , asthma , lung , mucus , immunology , infiltration (hvac) , allergic inflammation , immune system , biology , ecology , physics , thermodynamics
Since asthma is a multifactorial disease where treatment sometimes is not effective, new therapies that improve the respiratory discomfort of patients are of great importance. Phototherapy as Light‐emitting diode (LED) has emerged as a treatment that presents good results for diseases that are characterized by inflammation. Thus, our objective was to investigate the effects of LED on lung inflammation, by an evaluation of lung cell infiltration, mucus secretion, oedema, and the production of cytokines. Male Balb/c mice were or not sensitized and challenged with ovalbumin (OVA) and treated or not with LED therapy (1 h and 4 h after each OVA challenge). Twenty‐four hours after the last OVA challenge, analyzes were performed. Our results showed that LED treatment in asthmatic mice reduced the lung cell infiltration, the mucus production, the oedema, and the tracheal's contractile response. It also increased the IL‐10 and the IFN‐gamma levels. The effects of LED treatment on lung inflammation may be modulated by IL‐10, IFN‐gamma, and by mast cells. This study may provide important information about the effects of LED, and in addition, it may open the possibility of a new approach for the treatment of asthma.